Provided By GlobeNewswire
Last update: Apr 17, 2025
MALVERN, Pa., April 17, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced that the Company will report first quarter 2025 financial results on Thursday, May 8, 2025. TELA Bio’s management will host a conference call and webcast at 4:30 p.m. ET that day to discuss the financial results and provide a corporate update.
Read more at globenewswire.comNASDAQ:TELA (7/22/2025, 8:00:01 PM)
1.91
-0.07 (-3.54%)
Find more stocks in the Stock Screener